Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homocysteine and human reproduction.

T K Eskes

    Clinical and Experimental Obstetrics & Gynecology
    |February 24, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Elevated homocysteine levels, often due to MTHFR gene mutations, can impair cell growth and increase risks for neural tube defects and obstetrical vascular diseases. B-vitamin supplementation may help mitigate these risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Stereospecific in vitro embryotoxicity of l-homocysteine in pre- and post-implantation rodent embryos.

    Toxicology in vitro : an international journal published in association with BIBRA·2010
    Same author

    Homocysteine metabolism and effects of folic acid supplementation in patients affected with spina bifida.

    Neuropediatrics·2001
    Same author

    Clotting disorders and placental abruption: homocysteine--a new risk factor.

    European journal of obstetrics, gynecology, and reproductive biology·2001
    Same author

    [Link between prenatal exposure to the 'Winter of Famine' and long-term medical consequences].

    Nederlands tijdschrift voor geneeskunde·2001
    Same author

    Homocysteine-lowering effect of 500 microg folic acid every other day versus 250 microg/day.

    Annals of nutrition & metabolism·2001
    Same author

    Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis.

    Fertility and sterility·2000
    Same journal

    Can ACGME Milestones predict surgical specialty board passage: an example in Obstetrics and Gynecology.

    Clinical and experimental obstetrics & gynecology·2021
    Same journal

    Which patients on a gynecologic oncology service will require perioperative transfusion? A single-center retrospective cohort study.

    Clinical and experimental obstetrics & gynecology·2021
    Same journal

    Cantharidin is Superior to Trichloroacetic Acid for the Treatment of Non-mucosal Genital Warts: A Pilot Randomized Controlled Trial.

    Clinical and experimental obstetrics & gynecology·2018
    Same journal

    A case of placental mesenchymal dysplasia with one year follow-up.

    Clinical and experimental obstetrics & gynecology·2018
    Same journal

    Repeated cesarean scar pregnancy - Case report.

    Clinical and experimental obstetrics & gynecology·2018
    Same journal

    Iatrogenic parasitic myoma on the peritoneum of the right pelvic wall.

    Clinical and experimental obstetrics & gynecology·2018
    See all related articles

    Area of Science:

    • Biochemistry
    • Genetics
    • Obstetrics

    Background:

    • Homocysteine is an amino acid that can disrupt cell growth and is linked to pregnancy complications.
    • Hyperhomocysteinemia, or high homocysteine levels, is associated with neural tube defects and obstetrical vascular diseases like preeclampsia and placental abruption.

    Discussion:

    • Homocysteine is an independent risk factor for obstetrical vascular diseases, including thrombosis, preeclampsia, and placental abruption.
    • Low vitamin status (folic acid, B6, B12), MTHFR C677T mutation, and thrombotic factors are key risks for these conditions.

    Key Insights:

    • Folate can counteract MTHFR enzyme dysfunction and reduced activity.
    • B-vitamin status can modulate homocysteine levels and potentially prevent vascular diseases.

    Related Experiment Videos

    Outlook:

    • While placebo trials exist for neural tube defects, urgent trials are needed for obstetrical vascular diseases.
    • Cell proliferation requiring methyl groups is a potential common mechanism for homocysteine's effects on embryos and blood vessels.